Evidence map›Paper›PMID 31671729›Full record

ReviewInternational journal of molecular sciences2019

The Pathogenesis of Sepsis and Potential Therapeutic Targets.

Min Huang, Shaoli Cai, Jingqian Su

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 421 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
421citing papers in PubMed, 3 pooled it
31.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05636202 completednot on this mapstarted 2022, after this paper: background citation

The Early Predictive Roles of NLR and NE% in In-hospital Mortality of Septic Patients: a Single-center 13-year Retrospective Study

TypeobservationalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2022 to 2022Enrolled606ConditionsSepsis, InfectionsArmsNo intervention
NCT06991686 completednot on this mapstarted 2024, after this paper: background citation

Prognostic Value of Procalcitonin Vs Platelet/Total Leukocytic Count Ratio in 28 Days Outcome in Severe Septic Patients

Typeobservational_patient_registrySponsorAin Shams UniversityRan2024 to 2025Enrolled100ConditionsAll Conditions Causing Sepsis, Pneumonia - Bacterial, Urinary Tract Infection BacterialArmsBlood samples, blood sample
3 · Its place in the literature

Who cites it

421 citing papers in PubMed, 3 syntheses or guidelines pooled it, 738 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. [Protective effect of the endoplasmic reticulum stress inhibitor 4-phenylbutyric acid against myocardial injury in septic mice].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

361 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Min HuangBiomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou 350117, China. lll.suspendded@gmail.com.ORCID 0000-0002-4330-0340
Shaoli CaiBiomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou 350117, China. caishaoli@126.com.
Jingqian SuBiomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou 350117, China. sjq027@fjnu.edu.cn.
Fujian Normal University · CN

Funding

Innovative Research Teams Program II of Fujian Normal University in China IRTL1703, FZSKG2018013National Natural Science Foundation of China 81803547Natural Science Foundation of Fujian Province 2018J01720the Public Service Platform for Industrialization Development Technology of Marine Biological Medicine and Product of State Oceanic Administration FZHJ14
6 · The paper itself

Abstract

Sepsis is defined as "a life-threatening organ dysfunction caused by a host's dysfunctional response to infection". Although the treatment of sepsis has developed rapidly in the past few years, sepsis incidence and mortality in clinical treatment is still climbing. Moreover, because of the diverse manifestations of sepsis, clinicians continue to face severe challenges in the diagnosis, treatment, and management of patients with sepsis. Here, we review the recent development in our understanding regarding the cellular pathogenesis and the target of clinical diagnosis of sepsis, with the goal of enhancing the current understanding of sepsis. The present state of research on targeted therapeutic drugs is also elaborated upon to provide information for the treatment of sepsis.

Indexed as

AutophagyBiomarkersBlood Coagulation DisordersEndoplasmic Reticulum StressHumansIncidenceInflammationMitochondrial DiseasesNeuroendocrine CellsSepsisVirulenceBiomarkersbiomarkerspathogenesissepsistherapeutic drugs

Identifiers

PMID31671729
PMCPMC6862039
OpenAlexW2982027455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.